Healthcare NSE: DIVISLAB

Divi's Laboratories Financial Statements, P/E Ratio & ROE Valuation

Divi's Laboratories (DIVISLAB) — Drug Manufacturers - Specialty & Generic

₹8,349.00 INR

▼ ₹39.00 (-0.46%)

Overview Share Price Financials & P/E Dividends Shareholding Peer Comparison

Divi's Laboratories Financial Statements & Valuation Multiples

✨ Financials & Valuation Analysis

Divi's Laboratories commands a premium valuation with a P/E of 86.554016, supported by high market dominance and profitability expectations.

P/E Ratio (TTM) 86.554016

Forward P/E 56.108883

Price-to-Book (P/B) 13.22354

Return on Equity (ROE) N/A

Profit Margin 26.05%

Operating Margin 36.66%

EPS (TTM) ₹96.46

Enterprise Value ₹2.18 Lakh Cr

Financial Health & Profitability Breakdown for Divi's Laboratories

A comprehensive review of Divi's Laboratories reveals an ROE of N/A and operating profitability margins of 36.66%. Divi's Laboratories maintains high capital efficiency with an ROE of null% and operating margins of 36.66%, demonstrating robust cash generation capabilities.

Evaluating valuation metrics, Divi's Laboratories maintains a Price-to-Earnings ratio of 86.554016 and a Price-to-Book multiple of 13.22354. These valuation metrics, combined with an Enterprise Value of ₹2.18 Lakh Cr, provide essential indicators for fundamentally driven stock selection in India's Healthcare sector.

Frequently Asked Questions

What is Divi's Laboratories P/E ratio and Price-to-Book (P/B) ratio?

Divi's Laboratories trades at a trailing P/E of 86.554016, a Forward P/E of 56.108883, and a P/B ratio of 13.22354.

What is Divi's Laboratories Return on Equity (ROE)?

Divi's Laboratories reports a Return on Equity (ROE) of N/A, reflecting shareholder capital efficiency.

What are Divi's Laboratories profit margin and operating margin?

Divi's Laboratories maintains a net profit margin of 26.05% and an operating margin of 36.66%.

What is Divi's Laboratories Enterprise Value and EBITDA multiplier?

Divi's Laboratories has an Enterprise Value of ₹2.18 Lakh Cr and reported earnings per share (TTM EPS) of ₹96.46.

Explore Similar Healthcare Stocks

Explore Categories:

Technology Stocks Banking Stocks Nifty 50 Stocks Dividend Stocks Large Cap Stocks